Search - tctmd.com

Displaying 181 - 200 of 317

Sort: Relevancy | Date

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

April 16, 2018

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

News Daily News

European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban

March 23, 2018

Varicose Veins Linked to Increased Risk of DVT

News Daily News

Varicose Veins Linked to Increased Risk of DVT

February 28, 2018

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

News Daily News

Aspirin Switch for VTE Prevention After Hip/Knee Arthroplasty: Safe, Effective, and Cost-Saving in EPCAT II

Michael O'Riordan

February 21, 2018

PFO Diagnosis Linked With Increased Risk of Perioperative Ischemic Stroke After Noncardiac Surgery

News Daily News

PFO Diagnosis Linked With Increased Risk of Perioperative Ischemic Stroke After Noncardiac Surgery

Yael L. Maxwell

February 07, 2018

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

News Daily News

Migraine Associated With Broad Range of CVD Diagnoses in Nationwide Study

February 01, 2018

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

News Daily News

Using Multiple Arterial Grafts Appears to Improve CABG Outcomes

December 20, 2017

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

December 12, 2017

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

News Daily News

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

December 05, 2017

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

News Daily News

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

October 09, 2017

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

October 02, 2017

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

News Daily News

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

September 19, 2017

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

News Daily News

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

September 14, 2017

Prolonged Standing at Work Linked to Increased CV Risk

News Daily News

Prolonged Standing at Work Linked to Increased CV Risk

August 21, 2017

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

News Daily News

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

July 12, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.